Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Organic Letters called Reductive sp3-sp2 Coupling Reactions Enable Late-Stage Modification of Pharmaceuticals, Author is Mennie, Katrina M.; Vara, Brandon A.; Levi, Samuel M., which mentions a compound: 3395-91-3, SMILESS is O=C(OC)CCBr, Molecular C4H7BrO2, Product Details of 3395-91-3.
Late-stage derivatization of pharmaceutically relevant scaffolds relies on the availability of highly functional-group tolerant reactions. Reactions that increase the sp3 character of mols. enable the pursuit of more selective and well-tolerated pharmaceuticals. Herein, we report the use of sp3-sp2 cross-electrophile reductive couplings to modify a generic ATP-competitive kinase inhibitor with a broad range of primary and secondary alkyl halide coupling partners.
From this literature《Reductive sp3-sp2 Coupling Reactions Enable Late-Stage Modification of Pharmaceuticals》,we know some information about this compound(3395-91-3)Product Details of 3395-91-3, but this is not all information, there are many literatures related to this compound(3395-91-3).
Reference:
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem